ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 40 filers reported holding ETON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,845 | -81.5% | 922 | -82.9% | 0.00% | – |
| Q1 2023 | $20,740 | +86.7% | 5,387 | +36.8% | 0.00% | – |
| Q4 2022 | $11,108 | -20.7% | 3,939 | -38.8% | 0.00% | – |
| Q3 2022 | $14,000 | +40.0% | 6,433 | +70.7% | 0.00% | – |
| Q2 2022 | $10,000 | -50.0% | 3,768 | -17.3% | 0.00% | – |
| Q1 2022 | $20,000 | +17.6% | 4,555 | +11.7% | 0.00% | – |
| Q4 2021 | $17,000 | -48.5% | 4,079 | -23.9% | 0.00% | – |
| Q2 2021 | $33,000 | 0.0% | 5,363 | +19.4% | 0.00% | – |
| Q1 2021 | $33,000 | -26.7% | 4,492 | -19.0% | 0.00% | – |
| Q4 2020 | $45,000 | +40.6% | 5,545 | +38.5% | 0.00% | – |
| Q3 2020 | $32,000 | +23.1% | 4,004 | -16.3% | 0.00% | – |
| Q2 2020 | $26,000 | -7.1% | 4,783 | -28.9% | 0.00% | – |
| Q1 2020 | $28,000 | +55.6% | 6,731 | +164.0% | 0.00% | – |
| Q4 2019 | $18,000 | +100.0% | 2,550 | +114.5% | 0.00% | – |
| Q2 2019 | $9,000 | -86.8% | 1,189 | -86.1% | 0.00% | – |
| Q1 2019 | $68,000 | – | 8,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
| Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
| Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
| EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
| Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
| Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |